StonvexLoading…
StonvexStonvexStonvexCore line items from KBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $1.08B | $6.24B | $4.54B | $2.92B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $33.42M | $428.79M | $327.27M | $217.44M |
EPS (Diluted) | $0.52 | $6.15 | $4.60 | $3.00 |
Total Assets | $6.70B | $6.68B | $6.99B | $7.02B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $201.80M | $230.44M | $332.30M | $310.94M |
Free Cash Flow OCF − CapEx | $-138.59M | $287.28M | $-2.77M | $-188.61M |
Shares Outstanding | 63.73M | 69.25M | 70.64M | 72.11M |